TIRUMALCHM — Thirumalai Chemicals Balance Sheet
0.000.00%
- IN₹19.56bn
- IN₹38.55bn
- IN₹17.36bn
Annual balance sheet for Thirumalai Chemicals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 5,530 | 4,572 | 5,717 | 3,151 | 2,755 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1,645 | 1,258 | 2,000 | 3,146 | 1,970 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 10,310 | 10,525 | 11,338 | 9,610 | 7,968 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 6,595 | 10,773 | 19,111 | 26,035 | 37,688 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 18,616 | 23,602 | 33,203 | 38,068 | 47,366 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 5,553 | 8,655 | 10,289 | 9,260 | 12,973 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 7,766 | 11,683 | 21,741 | 26,511 | 31,730 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 10,850 | 11,919 | 11,462 | 11,557 | 15,636 |
| Total Liabilities & Shareholders' Equity | 18,616 | 23,602 | 33,203 | 38,068 | 47,366 |
| Total Common Shares Outstanding |